General information about company

Name of The CompanyEIKO LIFESCIENCES LIMITED
BSE Scrip Code540204
NSE SymbolNOTLISTED
MSE SymbolNOTLISTED
Date of Start of Financial Year01-04-2023
Date of End of Financial Year31-03-2024
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2023
Date of End of Reporting Period30-09-2023
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?No



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1Eiko Lifesciences LimitedAAACN0917CM/s. Urvi Speciality ChemicalsAABFU0392CPartnership Firm of DirectorPurchase of goods or services508.7500Textual Information(1)
2Eiko Lifesciences LimitedAAACN0917CMr. Umesh MoreAFMPM3924LWhole-Time Director of the CompanyRemuneration7300Textual Information(2)
3Eiko Lifesciences LimitedAAACN0917CMr. Jaid Ismail KojarAYBPK3762EChief Financial OfficerRemuneration93.600Textual Information(3)
4Eiko Lifesciences LimitedAAACN0917CAvi MundechaBUFPM9480CCompany Secretary of the CompanyRemuneration70.6700Textual Information(4)
5Eiko Lifesciences LimitedAAACN0917CLenus Finvest Private LimitedAACCL9703EDirector is member of Lenus Finvest Private LimitedPurchase of goods or services5002.10.380.38Textual Information(5)
6Eiko Lifesciences LimitedAAACN0917CCentrum FinserveAANFC9874DDirector is Partner in Centrum FinservInterest paid5002.6100Textual Information(6)
7Eiko Lifesciences LimitedAAACN0917CCentrum FinserveAANFC9874DDirector is Partner in Centrum FinservLoan50014000Textual Information(7)
8Eiko Lifesciences LimitedAAACN0917CCentrum FinserveAANFC9874DDirector is Partner in Centrum FinservAny other transactionLoan Repaid50014000Textual Information(8)
Total value of transaction during the reporting period300.73



Text Block

Textual Information(1)
Textual Information(2)
Textual Information(3)
Textual Information(4)
Mr. Avi Vijaykumar Mundecha has tendered his resignation with effect from close of working hours on May 18, 2023
Textual Information(5)
Textual Information(6)
Textual Information(7)
Textual Information(8)